Abstract -
INTRODUCTION

COMORBID
OPIATE ADDICTION and psychopathology have been the central themes in several recent scientific publications. Some authors described prevalences of the so-called 'dual diagnosis' problems (Abbot, Weller, & Walker, 1994; Darke, Wodak, Hall, Heather, & Ward, 1992; Hendriks, 1990; Raskin & Miller, 1993; Regier et al., 1990; Rounsaville, Weissman, Kleber, & Wilber, 1982; Swift, Williams, Neil1 & Grenyer, 1990) . Others discussed the causality of these problems (Lehman, My-ers, & Corty, 1989; Lehman, Myers, Thompson, & Corty 1993; Turnbull & Roszell, 1993) . Hypotheses, such as the possibility that different drug use patterns result in different types of psychopathology, were investigated also (Regier et al., 1990) . In these publications, the psychopathology has been assessed with various instruments. One of these is the Addiction Severity Index (Hendriks, Kaplan, Limbeck, & Geerlings, 1989; McLellan, Luborsky, Woody, & O'Brien, 1980) , which is used with increasing frequency in treatment programs, scientific studies, and for registration purposes. An important advantage of the AS1 is the multidimensional concept of addiction problems. This makes it possible to study problems in different aspects of life, including psychiatric problems within one instrument. As for addicted individuals with psychiatric comorbidity, for instance, the AS1 is capable of describing the nature and extent of drug problems as well as psychiatric problems (McLellan et al., 1983; Rounsaville, Kosten, Weissman, & Kleber, 1986; Stoffelmayer, Benishek, Humphreys, Lee, & Mavis, 1989) . Although the AS1 was never meant for screening on psychopathology, it has been used as such in practice by clinicians and researchers.
However, given the complex nature of the comorbid psychiatric and addiction problems (Lehman, Myers, Dixon, & Johnson, 1994) , there is a disadvantage to the ASI. The psychiatry section results in a dimensional measure, expressing severity that is not specific enough to describe the psychiatric problems in terms of a classification system, such as for instance categorical DSMIll-R disorders. Instruments that provide a better distinction between symptom level and disorder level on the one hand contribute to an improved insight in the problem complexity by describing types of psychopathology. But, on the other hand, they require considerably more interview time, which is often lacking in treatment settings and research situations. Information about the relation between the AS1 psychiatry section and specific psychiatric disorders may be useful for those clinicians who are not able to conduct an elaborate psychiatric interview. Therefore, the aim of this paper is to describe to what extent the psychiatry section of the AS1 reflects DSM-III-R disorders, assessed with the Composite International Diagnostic Interview (Robins et al., 1989 ). An earlier study of Hendriks (1990) showed that, compared with the psychiatric symptom check list SCL-90 (Derogatis, 1983 ) and the Beck Depression Inventory (Beck, Ward, Mendelson, Mock, & Erbaugh, 1961 ) the AS1 was the best screening instrument for anxiety-related disorders and depressive disorders. Among opiate-addicted individuals who participated in a residential detoxification program, 8 1% of the psychopathology cases could be identified with a severity rating of 5 or higher in the psychiatry section of the ASI. In this instance, 55% of the cases without psychopathology were correctly identified.
MATERIALS AND METHODS
Subjects
The central topic of this publication is part of a larger study in which opiate-addicted individuals in and outside of treatment are compared. During a period of about 30 months in which data were gathered, 327 opiate-addicted individuals were interviewed. The respondents had been dependent on opiates for at least the past 2 years, which is in accordance with DSM-III-R criteria, and they were 18 years or older. Respondents who stayed in the treatment setting for less than 2 weeks were excluded from the study. Subjects were acquired in four settings. In a low-threshold methadone program, 91 respondents were selected on consecutive admission; every third respondent who applied for the program was approached. In a clinical detoxification program, 72 respondents who did not continue their treatment with a therapeutic community (TC) (detox only) and 77 who did continue their treatment in a TC were interviewed. All subjects in treatment were interviewed at intake and signed a form of consent. Interviews were conducted by trained staff of the treatment settings. There were regular meetings during which the researcher commented on the interviews. 83 opiate-addicted individuals without treatment were interviewed. They had not received treatment for more than 2 weeks over the past 2 years. They were selected by means of the snowball sampling method with nominee selection (Hendriks, Blanken, & Adriaans, 1992) . In this method, the interviewed respondent names about six other heroin users without treatment contacts. Of these, one is randomly selected and interviewed. All subjects outside of treatment were paid for their participation. The fieldwork was carried out by the researcher and a community fieldworker who was trained in interview techniques. The nonresponse numbers in the different settings were: community: 22% of the users identified by the chain referral method could not be located or refused to participate and 9% of the approached users did not show up at the second or third appointment; methadone: 26% of the approached users refused participation or did not show up; inpatient: 9% of the respondents left the setting before the required 2 weeks and, therefore, no CID1 interview was recorded. AS1 interviews of 11% of the inpatient heroin users could not be retrieved by the treatment setting. The sociodemographic characteristics of the lost respondents in the treatment settings did not differ from those of the interviewed users.
Procedure
Two instruments were used. The Dutch version of the Addiction Severity Index (ASIR) (Hendriks et al., 1989; McLellan et al., 1980) was used to collect information on several life aspects. These are physical health, employment, alcohol and drug use, legal status, social functioning, and psychiatric problems. Both lifetime and current problems are addressed. For every area an overall "severity rating" was established; this rating was chosen in a range from 0 (no problems/no need for help) to 9 (extreme problems/extreme need for help). Composite scores were also computed, based on recent items of the ASIR (Hendriks et al., 1989; McLellan et al., 1985) . These composite scores are considered to be more objective than the severity ratings, because the interviewer's opinion does not play a role. The Composite International Diagnostic Interview (CIDI) (Robins et al., 1989) was administered to describe the respondents' psychopathology in terms of DSM-III-R disorders. The disorders were grouped into three categories that were previously used by other researchers (Hendriks, 1990; Limbeek et al., 1992; Rounsaville et al., 1982) . Recent disorders only (last 6 months) are presented. Major depression, dysthymia, and manic disorder were united in the category "affective disorders." Generalized anxiety, obsessivecompulsive disorder, agoraphobia, and panic disorder together constituted the category "anxiety disorders." So- cial and simple phobias were left out because too many respondents were classified in the anxiety category due to only one of these, relatively light, phobias. The third category was antisocial personality disorder (ASP). Lifetime schizophrenic disorders make up the fourth category.
Data Analysis
In general, there are two kinds of overall measures in the ASI: severity ratings and composite scores. When the AS1 is used as a screening instrument to identify addicted individuals with psychiatric problems, cut-off points can be used to distinguish between respondents with and without those problems. The choice of such a cut-off point is based more often on intuition than on empirical data. To find out to what extent certain psychiatric disorders were screened, validity measures of sensitivity and specificity of the diagnoses were obtained by comparing the AS1 psychiatric overall measures at several cut-off points with the criterion (CIDI). There could be four possible combinations. True-positive (TP) and true-negative (TN) classifications occur when the two types of data agree, false-positive (FP) and false-negative (FN) classifications occur when the two types of data disagree. Sensitivity refers to the percentage of persons with a disease and who are classified by the test as having the problems (TP/'TP + IN). Specificity points at the percentage of persons without the disease and who were classified by the test as not having the problems (TN/FP + TN) (Bouter & van Dongen, 1991) .
RESULTS
The results will be presented in four parts. First, it is described to what extent the ASIR is capable of screening individuals who have one or more psychiatric disorders. Second, data for categories of psychiatric disorders are presented which concern the different levels of severity ratings of the ASIR psychiatry section, and, thirdly, data for comparable categories that concern the different levels of composite scores of the psychiatry section. Finally it is described to what extent the DSM-III-R disorders are screened at ASIR item level.
Screening Respondents with One or More Disorders
Of the 99 respondents with a recent anxiety disorder, affect disorder or schizophrenic disorder, it appeared that 43% received a severity rating of 6 or higher at the psychiatry section of the ASIR. For a cut-off point of 5 this was 59% and for a cut-off point of 4, 13% of these respondents were identified. When ASP disorder is included, the number of respondents with a recent disorder is 169. At a cut-off point of 6, 33% is screened well. At a cut-off point of 5, 50% was identified, and at a cut-off level of 4 and higher 66% was identified. Lower cut-off points screen worse. Table 1 shows to what extent respondents with none, one, or more recent psychiatric disorder (excluding ASP disorder) were screened accurately by the psychiatry section of the ASIR. That the data of this section are not totally compatible with the DSM-III-R data becomes clear from these results. Respondents without a recent psychiatric disorder received severity ratings of 4 or 5. A cut-off point of 6 was able to distinguish the respondents with a recent disorder from those without. For the respondents with 1, 2, or 3 and more disorders it appeared that a low cut-off point screened reasonable. This improved for respondents with more disorders.
Severity Ratings
The results in Table 2 represent the relation between the ASIR psychiatry ratings and the CID1 diagnoses. The severity ratings were divided into three categories (Low, Mid, and High), previously used by McLellan et al. (1983) and Hendriks (1990) . It was expected that the percentage of respondents with a particular disorder would increase from the low to the middle group and from the middle to the high group. It emerged that this was true with respect to anxiety disorders and schizophrenia, but not with respect to affective disorders and ASP disorders. The number of respondents with an affective disorder in the middle group was 27.0%, which was not very different from the 30.8% of the high group. For ASP disorders the number of respondents with this disorder was comparable across all three ASIR categories. This reflects the different character of this Axis II (personality) disorder compared to the other Axis I disorders, which are better reflected in the severity ratings. Table 3 describes to what extent affective, anxiety, schizophrenic disorders and ASP disorder categories (CIDI) were identified correctly at several cut-off points of the ASIR's psychiatric severity rating. Of the four categories, ASP disorder appeared to be identified worse. At a cutoff score of 5, 58% of the cases were well identified, while the other categories scored about 65% at this point.
Composite Scores
In order to describe the relation between the ASI@ composite scores and CID1 diagnoses, Table 4 represents percentages of users across the different ASI@ categories with a low, middle, or high composite score. The three categories of composite scores have been formed by calculating the mean (M = 0.24), ? 1 standard deviation (SD = 0.23). This procedure was used previously by McLellan et al. (1983) and Stoffelmayer et al. (1989) . Because the composite scores range from 0 (no problems) to 1 (severe problems) it was expected that the high category would contain the largest number of respondents with a particular disorder. However, it appeared that the middle group consisted of the largest number of respondents who suffered from recent disorders in all four categories. This might be a result of the composite score being based on only the recent items of the ASIR, whereas the severity rating includes past (lifetime) psychiatric symptoms as well. Indeed, further analyses showed that the lifetime average number of DSM-III-R disorders was significantly larger in the high group (2.83) compared to the middle group (2.18) and the low group (1.33) (p = 0.00). This indicates that long-term psychiatric information plays an important role in the assessment of the psychiatric severity of psychiatric problems with the ASI@. 123) and 74.3% of respondents without recent anxiety disorders. Table 5 represents the results of screening CID1 disorders at three cut-off points. When the data were cut off above the mean, respondents with affective disorders were identified best of all (64.3%), followed by ASP disorder (60.1%) anxiety disorders (58.1%) and lifetime schizophrenic disorders (54.7%). However, these percentages show that there are no major differences between the various disorders.
CONCLUSION AND DISCUSSION
Finally, some comparisons were made at item level of the ASIR. Of the respondents with a lifelong major depression or dysthymia (N = 95), 81.3% was screened by the ASIR question of whether they had ever been depressed, while 47.2% of respondents without the disorder were correctly classified. Of the respondents with a recent depressive disorder on the CID1 (N = 61) 57.4% was identified by the ASIR question of whether they had been depressed in the past month, whereas 71.6% without depressive disorders scored negatively at the ASIR depression question. Of the lifetime anxiety disorders (N = 181), 65.7% of respondents were correctly identified by the ASIR, and 58.1% of respondents without the disorder were screened correctly. The ASIR recognized 46.3% of respondents with recent anxiety disorders (N = A limitation of this study is that the CID1 diagnoses, which are considered the "golden standard" in this comparison, are also assessments with a better or worse sensitivity and specificity, A comparison with, for instance, clinically assessed disorders might give an indication of the quality of the CID1 results, but even these clinically assessed disorders are not watertight. For example, Kranzler et al. (1995) compared the validity of psychiatric diagnoses that were obtained by a clinical interview (SCID) conducted by a Master's level clinician with the validity of diagnoses that were the result of a nonclinician conducting a-standardized interview. They concluded that the psychiatric diagnosis in substance abuse patients may be improved by the addition of elements of structured interviews to the clinician's usual assessment. For the CIDI, several publications showed good validity of almost all diagnoses except for psychotic disorder (Farmer, Katz, McGuffin, & Bebbington, 1987; Janca, Robins, Cottler, & Early, 1992; Semler, 1989; Sprengler & Wittchen, 1989) .
Furthermore, the reliability of the results in this study might be limited because data are based on retrospective self-reports of the respondents who were often under the influence of drugs. During the fieldwork, respondents suffering heavy withdrawal symptoms or strong intoxication were not interviewed, but in those cases the appointment was rearranged for another time. We expect the chances of deliberately falsified answers to be small, because there were no financial or other consequences attached to the answers. The present results indicate that the ASIR psychiatry section detects part of the psychopathology cases, but also misses out on a substantial number. For instance, at item level, 18.7% of respondents with lifetime depression were missed out and 34.3% of respondents with lifetime anxiety disorders. Also, at the severity rating level, about 35% of respondents with anxiety, affective, or schizophrenic disorders were missed out at a cut-off level of 5. The detection of ASP disorder was worse. The number of respondents in the group with middle severity ratings (4-6) that reported ASP disorder was larger than in the high group (7-9). At the various cut-off levels the percentage of correctly identified cases with respect to ASP disorder also remained low. This indicates that Axis II personality disorders such as ASP are of a different nature when compared to the Axis I disorders.
One reason for these differences between the instruments is that in a structured psychiatric interview, all DSM-III-R symptoms of a disorder are investigated, which results in a categorical diagnoses at disorder level. For each symptom it is checked whether it is severe enough, whether it results from a physical illness or from substance use, whereas the ASIR psychiatry section measures more at symptom level. It is less extensive and it integrates the information about different types of psychiatric symptoms into a dimensional measure to indicate the severity of the psychiatric problems, regardless of the type of psychopathology.
The latter screens only part of the psychopathology cases. Another explanation for the differences that were found between the instruments could be the conclusion of Raskin and Miller (1993) that psychiatric symptoms that are common in active addiction are mainly symptoms that generally disappear within weeks or months of treatment for addiction. Because the CID1 results are described at disorder level, many symptoms might not pass this threshold of the disorder level, while these are screened by the ASIR. A comparison of the sensitivity and specificity of the ASIR psychiatry severity rating and the psychiatric composite score shows that the severity rating approaches the recent CID1 diagnoses better than the composite scores. When the scores were compared across three groups (low, mid, high), it turned out that not the highest group but the middle group consisted of the largest number of respondents with psychiatric disorders. This indicates that the inclusion of lifetime items of the ASIR psychiatry scale, as is the case with severity ratings, improves comparability with the CID1 results.
What is the best cut-off point to screen a particular type of psychopathology depends on several factors, such as the nature of the disease, the available money, and the consequences for the people undergoing the test-all play a part. For example, a high sensitivity is required with regard to diseases that would deteriorate without treatment, but that can be successfully treated if they are detected in time. A sensitive test is also useful in order to eliminate people without diseases at the start of the diagnostic process. A negative consequence of choosing a high sensitivity is that persons are sometimes labelled as psychiatric (false positives) without reason. This may lead to emotional damage or medical overconsumption. (Bouter & van Dongen, 1991) . The current study considers mental disorders. The negative effect of severe psychiatric comorbidity on the prognosis for treatment (McLellan et al., 1983; Rounsaville, Dolinsky, Babor, & Meyer, 1987) underlines the importance of thoroughly screening these disorders. Therefore, a cut-off point with high sensitivity seems most appropriate. Yet another reason for choosing a high sensitivity is that the nature of the psychopathology in opiate-addicted individuals might not be apparent at first sight. When screening takes place at the moment of intake, the chances are that psychological symptoms dissolve during the first weeks of treatment. Therefore, it seems more appropriate to choose for a large number of false positives in order to end up with the true psychiatric disorders.
Implications of the results are that the ASIR psychiatry section should only be used very carefully for assessment of psychopathology in opiate-addicted individuals. Because of the low agreement between ASIR data and DSM-III-R disorders, we advise using the ASIR psychiatry section for the first step in a screening process only. The next step would be a clinician's opinion or a more extensive instrument to assess psychopathology.
Unfortunately, both take extra time, which might not be available. If this is the case, a relatively low cut-off point, say four, should be used in order not to miss out too many addicted individuals with a disorder. The consequence of this method is that the extra number of false positives that are necessary to find the number of true positives requires additional financial resources. Also, with respect to the rather large number of false positives, especially those in treatment, it is important not to label the client as "psychiatric" based on ASIR information alone.
